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2208Objectives: The technical performance score (TPS) has been reported in a single center study to predict the
outcomes after congenital cardiac surgery. We sought to determine the association of the TPS with outcomes
in patients undergoing the Norwood procedure in the Single Ventricle Reconstruction trial.
Methods: We calculated the TPS (class 1, optimal; class 2, adequate; class 3, inadequate) according to the
predischarge echocardiograms analyzed in a core laboratory and unplanned reinterventions that occurred before
discharge from the Norwood hospitalization. Multivariable regression examined the association of the TPS
with interval to first extubation, Norwood length of stay, death or transplantation, unplanned postdischarge
reinterventions, and neurodevelopment at 14 months old.
Results:Of 549 patients undergoing aNorwood procedure, 356 (65%) had an echocardiogramadequate to assess
atrial septal restriction or arch obstruction or an unplanned reintervention, enabling calculation of the TPS. On
multivariable regression, adjusting for preoperative variables, a better TPS was an independent predictor of a
shorter interval to first extubation (P ¼ .019), better transplant-free survival before Norwood discharge
(P<.001; odds ratio, 9.1 for inadequate vs optimal), shorter hospital length of stay (P<.001), fewer unplanned
reinterventions between Norwood discharge and stage II (P ¼ .004), and a higher Bayley II psychomotor deve-
lopment index at 14 months (P¼ .031). The TPS was not associated with transplant-free survival after Norwood
discharge, unplanned reinterventions after stage II, or the Bayley II mental development index at 14 months.
Conclusions: TPS is an independent predictor of important outcomes after Norwood and could serve as a tool
for quality improvement. (J Thorac Cardiovasc Surg 2014;148:2208-14)See related commentary on pages 2214-5.Supplemental material is available online.e Children’s Hospital Boston and Harvard Medical School,a Boston,
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Abbreviations and Acronyms
ASD ¼ atrial septal defect
IQR ¼ interquartile range
LOS ¼ length of stay
MDI ¼ mental developmental index
PA ¼ pulmonary artery
PDI ¼ psychomotor developmental index
SVR ¼ single ventricle reconstruction
TPS ¼ technical performance score
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Dan optimal TPS mitigated the effects of the preoperative
physiologic status and illness severity during the initial
hospital stay.2,3,9 However, the TPS requires validation in
a multicenter study.
We sought to determine the validity of TPS across
multiple centers using the database from the Pediatric Heart
Network’s Single Ventricle Reconstruction (SVR) trial.10-15
Specifically, we explored whether the TPS could predict
early and late outcomes, including resource usage. We
hypothesized that the TPS could also identify patients at
higher risk of reintervention in the interstage phase.METHODS
We performed a secondary analysis of the data from the SVR trial, for
which the inclusion and exclusion criteria, study design, and data collection
have been previously described.10-15
Technical Performance Scoring System
All subjects were assigned a TPS according to the following data
obtained before Norwood hospital discharge: postoperative, protocol-
driven transthoracic echocardiographic findings interpreted by a core
laboratory and unanticipated surgical or catheter-based reintervention in
the areas of Norwood repair before discharge from the hospitalization
associated with the Norwood procedure. The TPS module used in our
analyses, as modified from the original reported by Bacha and colleagues,2
is summarized in Table E1.
In brief, the surgical procedures were divided into components that
were assigned a score of class 1 (optimal), class 2 (adequate), or class 3
(inadequate) according to specific echocardiographic criteria and the occur-
rence of unplanned reinterventions at surgical repair sites before discharge
from the Norwood hospitalization (Table E1). The overall classification of
the operation as class 1, 2 or 3was determined from the highest class assign-
ment for any of the component subprocedures. All components of the Nor-
wood TPS module in its current version were given equal weight.
Two additional classes were created to allow the inclusion of all subjects
in the SVR trial. Class 4 included subjects who had had no core laboratory
echocardiograms and no unanticipated reinterventions in the area of
Norwood repair before discharge or death. Class 5 included subjects
with echocardiograms inadequate for TPS assignment and no unanticipated
Norwood surgical reinterventions before discharge or death.
Outcomes
Our primary outcome was the interval to the initial endotracheal
extubation, because it is a well known surrogate for resource usage. We
did not choose mortality as our primary endpoint because a vast majority
of class 4 (no echocardiogram) patients died and thus could not beThe Journal of Thoracic and Carassigned a TPS. The secondary outcomes included early mortality or
transplantation, defined as occurring before Norwood discharge or within
30 days of the Norwood procedure if discharged before 30 days, whichever
was longer; Norwood hospitalization length of stay (LOS); late mortality or
transplantation; unplanned reinterventions after Norwood discharge; and
the psychomotor development index (PDI) and mental development index
(MDI) scores of the ‘‘Bayley Scales of Infant Development, 2nd edition.’’
Classification of Unplanned Reinterventions After
Norwood Discharge
The following postdischarge reinterventions were considered to be
attributable to the Norwood procedure technique: (1) any reintervention
on the aortic arch, atrial septum, or ascending aorta or proximal pulmonary
artery (PA) connection; (2) extensive PA rehabilitation, excluding simple
PA augmentation at the stage II or Fontan procedure; and (3) any reinter-
vention on the modified Blalock-Taussig shunt or right ventricle-to-PA
shunt between Norwood discharge and the stage II procedure.
The following postdischarge reinterventions were considered not to be
attributable to the Norwood procedure technique: (1) coiling of the
aortopulmonary or venovenous collaterals; (2) an uncomplicated stage II pro-
cedure or Fontanprocedure; and (3) any intervention on the superior vena cava
after the stage II procedure or Fontan connections after the Fontan procedure.
Statistical Analysis
The distributions of patient and procedural characteristics by TPS class
were compared using the chi-square or Fisher exact test for categorical
variables and the Kruskal-Wallis test or 1-way analysis of variance for
continuous variables.
Cox regressionmodeling identified the factors associatedwith the interval
to the initial extubation. The factors associated on univariate analysis at the
0.20 level were candidate predictors for stepwise multivariable modeling.
Ourmultivariable analyses included only the patient factors and preoperative
medical variables, because the intraoperative and postoperative outcomes
were in the causal pathway of the measures used to calculate the TPS. The
TPS was then added to the multivariable model to assess whether it was an
independent predictor. Kaplan-Meier estimation with the log-rank test
described the association of the interval to initial extubation and the TPS.
The same approach was applied to the secondary outcome variables, using
linear regression for continuous variables and logistic regression for dichot-
omous outcomes. We assessed the reliability of the TPS as an independent
predictor of each outcome by creating 1000 samples with bootstrapping to
determine the percentage of samples in which the TPS was significant at
the 0.05 level, conditional on the demographic and preoperative variables
already in the multivariable model. A reliability of50% was set as the cri-
terion for retaining the TPS term as an independent predictor.
We assessed whether the 3 components of the TPS (distal arch gradient,
atrial septal defect [ASD] gradient, and unplanned reinterventions before
Norwood discharge) were associated with Norwood hospitalization LOS,
early mortality or transplantation, and reintervention before the stage II
procedure. For the echocardiographic components, the medium and high
categories for the distal arch gradient and the mean ASD gradient were
combined before modeling owing to sparse data.
Sensitivity analyses were also conducted, using the data from subjects
withmissing and incomplete echocardiograms (class 4 and 5, respectively).
The TPS was assumed to be optimal for all, and then inadequate for all, to
set the bounds on the relationships between the interval to initial extubation
and technical performance.
All analyses were performed using Statistical Analysis Systems, version
9.3 (SAS Institute, Cary, NC).
RESULTS
The SVR trial randomized 555 subjects, of whom 5 did
not undergo a Norwood procedure and 1 withdrew in thediovascular Surgery c Volume 148, Number 5 2209
FIGURE 1. Interval to first extubation, early mortality, and Norwood hospital length of stay stratified by technical performance score class. Class 3 subjects
had a significantly longer interval to first extubation, greater early mortality, and longer Norwood hospital length of stay.
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Dfirst week. Of the remaining 549 subjects, 485 (88%) had
postoperative echocardiograms adequate for calculating
the TPS, and 452 (82%) survived transplant-free to
Norwood discharge. Protocol-driven echocardiograms
were performed at a median of 14 days (interquartile range
[IQR], 8-21) postoperatively. A TPS could be assigned to
356 subjects (65%) using the echocardiograms or because
of unanticipated reinterventions in the areas of Norwood
repair. An additional 56 subjects (10%) were class 4 and
137 (25%) class 5. The baseline characteristics are listed
in Table E2. The subjects in class 4 (no echocardiogram)
had the lowest birth weight and the highest prevalence of
preterm birth and percentage of unknown genetic status.
No difference was found in the patient factors between
those in class 5 and those with an assigned TPS
(Table E3). Among the subjects with a TPS, the distribution
was class 1 for 72%, class 2 for 12%, and class 3 for 17%.
Interval to First Extubation
Of the 452 subjects (82%) discharged after the Norwood
procedure alive without transplantation, those with TPS
class 3 underwent extubation later than those in class 1 or
2 (log-rank test, P<.001; Figure 1), with a median interval
to extubation of 9 days (IQR 5-15), 6 days (IQR, 4-8), and 6
days (IQR, 3-7), respectively. After adjusting for center, the
variables independently associated with a longer interval to
first extubation included lower gestational age, Hispanic
ethnicity, and the presence of a genetic syndrome or
anomalies (model R2 ¼ 0.21). When added to this model,
TPS was an independent predictor (model R2 ¼ 0.23,
P ¼ .019, 76% reliability). Class 3 subjects had a longer
interval to first extubation (Table 1).
Early Mortality or Transplantation
Three pre-Norwood characteristics were independently
associated with early mortality or transplantation:
obstructed pulmonary venous return, cardiac or other
surgery before the Norwood operation, and genetic
syndrome or anomalies. When added to this model, TPS
was an independent risk factor (P<.001, 98% reliability).2210 The Journal of Thoracic and Cardiovascular SurClass 3 subjects had greater odds of early mortality or trans-
plantation, and class 1 and 2 subjects had similar risks of
early mortality or transplantation (Table E4 and Figure 1).
The R2 increased from 0.14 to 0.26 (Table 2).
NorwoodHospital LOS in Transplant-Free Survivors
The median LOS (n ¼ 329) was significantly longer in
those in class 3 than in those in class 1 and 2 (median 50 vs
23 and 20 days, respectively; Figure 1). The TPS was an in-
dependent predictor of the Norwood LOS (P<.001, 100%
reliability) when added to the multivariable model that
included center and genetic syndrome or anomalies. The R2
increased from 0.15 to 0.20 (Table 3).
Late Reinterventions Attributable to the Norwood
The data were analyzed in 2 periods: after Norwood
discharge but before stage II and after the stage II procedure.
Of the 329 subjects with a TPS class, including 37 (11%)
who died between Norwood discharge and stage II surgery,
those in class 1 were the least likely to have required
reintervention between Norwood discharge and stage II
(logistic regression, P ¼ .003; 78% reliability; Table 4
and Table E5). The TPS was not associated with late
reinterventions from the stage II operation to age 12 months.
Mortality or Transplantation After Norwood
Discharge
Of the 448 transplant-free survivors to Norwood
discharge, 96 had died (n ¼ 85) or underwent transplanta-
tion (n ¼ 11) by 3 years after randomization. The
independent predictors of a greater hazard of death or
transplantation between Norwood discharge and 3 years
after randomization included preterm delivery, obstructed
pulmonary venous return, and greatest pre-Norwood lactate
level. When added to this model, the TPS was not an
independent predictor (Tables E6 and E7).
Neurodevelopmental Outcomes
The distributions of the PDI and MDI scores are
presented in Figure E1. The independent preoperativegery c November 2014
TABLE 1. Multivariable Cox regression model for interval to first
extubation* (n ¼ 324, R2 ¼ 0.23)
Variable HR 95% CI P value
Center <.001
Gestational age (mo) 0.88 0.82-0.95 <.001
Hispanic .03
Yes 1.40 1.04-1.90
No Reference
Genetic syndrome or other anomalies .03
Yes 1.51 1.12-2.06
No Reference
Unknown 1.19 0.84-1.66
TPS .02
Class 1 (optimal) 0.59 0.41-0.85
Class 2 (adequate) 0.62 0.38-1.00
Class 3 (inadequate) Reference
All P values were statistically significant. HR, Hazard ratio; CI, confidence interval;
TPS, technical performance score. *Excluding data from subjects who had died or
underwent cardiac transplantation during hospitalization.
TABLE 3. Multivariable Cox regression model for Norwood length of
stay* (n ¼ 329, R2 ¼ 0.20)
Variable HR (95% CI) P value
Center .01
Genetic syndrome or other anomalies .001
Yes 1.63 (1.21-2.19)
No Reference
Unknown 1.65 (1.18-2.30)
TPS <.001
Class 1 (optimal) 0.44 (0.31, 0.63)
Class 2 (adequate) 0.35 (0.22, 0.56)
Class 3 (inadequate) Reference
Pre-Norwood complication .03
Yes 1.33 (1.02-1.72)
No Reference
All P values were statistically significant. HR, Hazard ratio; CI, confidence intervals;
TPS, technical performance score. *Excluding data of subjects who died or
underwent cardiac transplant during the hospitalization.
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Dpredictors of a lower PDI score were center, lower birth
weight, and genetic syndrome or anomalies. When the
TPS was added to the model, a worse TPS class was
associated with a lower PDI score (P ¼ .031, 66%
reliability), with the model R2 increasing from 0.19 to
0.22. A lower MDI score was independently associated
with center, lower birth weight, lower Apgar score at
1 minute, intubation for respiratory failure or metabolic
acidosis, and genetic syndrome or anomalies. When added
to this model, the TPS class was not associated with the
MDI score.
TPS Components
We analyzed the 3 components of the TPS available in
the SVR trial database (distal arch gradient, ASD gradient,
and unplanned predischarge reintervention in the areas of
Norwood repair) to test their associations with the selected
outcomes. Unplanned predischarge reinterventions in the
areas of Norwood repair could occur in any component of
the Norwood TPS. The reinterventions that resulted in classTABLE 2. Multivariable logistic regression model for early death or
transplantation (n ¼ 356, R2 ¼ 0.26)
Variable OR 95% CI P value
Pre-Norwood intubation 2.38 1.01-5.61 .05
Genetic syndrome or other anomalies .002
Yes 0.83 0.23-3.01
No Reference
Unknown 4.43 1.72-11.4
TPS <.001
Class 1 (optimal) 0.11 0.04-0.26
Class 2 (adequate) 0.19 0.05-0.75
Class 3 (inadequate) Reference
All P values were statistically significant. OR, Odds ratio; CI, confidence interval;
TPS, technical performance score.
The Journal of Thoracic and Car3 TPS assignment are listed in Table E8, and the
echocardiographic findings in the 59 subjects assigned to
class 3 are summarized in Table E9. In multivariable
analysis, pre-Norwood discharge reintervention was
significantly associated with a greater early mortality or
transplantation rate (odds ratio, 8.36; 95% confidence
interval, 3.54-19.7; P<.001) and longer median Norwood
LOS (51 days, IQR, 33-86; vs 23 days, IQR, 16-36;
P < .01). A distal arch gradient of 20 mm Hg was
significantly associated with a greater odds of prestage II
reintervention (odds ratio, 3.28, 95% confidence interval,
1.59-6.76; P<.001). The ASD gradient was not associated
with these 3 outcomes.Sensitivity Analyses
To assess the effect of the exclusion of class 5
(incomplete echocardiograms) on the interval to first
extubation, we included 137 class 5 subjects in the Cox
regression analyses under 2 extreme assumptions: that
all were class 1 and that all were class 3. When all class
5 subjects were assumed be class 1, the TPS remained aTABLE 4. Multivariable logistic regression model for prestage II
reintervention (n ¼ 318, R2 ¼ 0.12)
Variable OR 95% CI P value
Prenatal diagnosis of CHD .01
Yes 2.77 1.24-6.18
No Reference
SES score 1.06 1.01-1.12 .03
TPS .01
Class 1 (optimal) Reference
Class 2 (adequate)* 2.93 1.41-6.11
Class 3 (inadequate) 2.02 0.94-4.32
All P values were statistically significant. OR, Odds ratio; CI, confidence interval;
CHD, congenital heart disease; SES, socioeconomic status; TPS, technical
performance score. *Class 2 versus 3 did not differ (P ¼ .681).
diovascular Surgery c Volume 148, Number 5 2211
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when all class 5 subjects were presumed to be class 3, the
TPS was no longer associated (P ¼ .99) with the interval
to first extubation. However, because the characteristics of
the subjects with an incomplete echocardiogram were
similar to those with an assignable TPS, this latter
sensitivity assumption (100% class 3) was discordant
with the observed percentage of subjects with a score who
were assigned to class 3 (17%).
We did not perform a sensitivity analysis regarding the
interval to first extubation for class 4 (no echocardiogram),
because only 2 of the 56 class 4 subjects survived to
Norwood discharge and had interval-to-extubation data.
Instead, we performed a sensitivity analysis using the
regression model for early mortality or transplantation
and included the class 4 subjects, assuming that all had
either class 1 or 3 TPS. When class 4 subjects were all
assumed to be class 1, the TPS remained associated
(P¼ .050) with early mortality or transplantation. However,
we would expect that class 4 subjects would be most likely
to have had an inadequate TPS (class 3) rather than an
optimal TPS (class 1), because 96% of the class 4 subjects
died or underwent transplantation. When the class 4
subjects were all assigned to class 3, the TPS was strongly
associated with mortality (P<.001).
DISCUSSION
Although the role of human factors in the outcomes
after surgery has been well described,16-18 the technical
adequacy of the repair could still be the single most
important factor in determining the outcomes. This
premise has been proved in other surgical fields19-21 in
which assessment models have been based on methods
such as video recordings, and models of surgical skills
assessment have been incorporated into surgical training
programs.22-25 However, a tool using routine clinical
information for measurement of technical adequacy has
not been validated. As previously described at a single
center,3-9 the TPS is based on information available
from routine clinical care, including postoperative
echocardiographic findings and reintervention in the
anatomic areas of surgical repair. Moreover, the TPS has
been associated with early outcomes, such as mortality,
major adverse events, longer LOS, and higher costs, and
mid-term outcomes after hospital discharge, such as
transplant-free survival and unplanned reinterventions.
In the present multicenter study, we found that the TPS
was an independent predictor of both early and mid-term
outcomes after the Norwood procedure. Specifically, our
multivariable model, which included baseline patient
factors and preoperative variables, found that a worse TPS
was significantly associated with a longer interval to first
extubation, greater early mortality or transplantation, a
longer Norwood LOS, more unanticipated interventions2212 The Journal of Thoracic and Cardiovascular Surbetween Norwood discharge and the stage II procedure,
and lower PDI scores at 14 months of age. We did not
find an association between the TPS and unanticipated
reinterventions after the stage II procedure, the 14-month
MDI score, or late mortality or transplantation. The
association of a worse TPS with a lower 14-month PDI
score but not MDI score is consistent with the nearly
universal observation that the PDI scores are more
affected than the MDI scores in children with congenital
heart disease.26-29 Early death in subjects with inadequate
repair might explain the lack of an association of the
TPS with late mortality or transplantation and the greater
rate of reintervention before stage II among the subjects
in class 2 compared with class 3. Analyses of the
components of the TPS showed that reinterventions were
significantly associated with early mortality and Norwood
LOS, and higher arch gradients were associated with
prestage II reinterventions. The present multicenter study
has validated the generalizability of the TPS across
centers that vary widely in geographic location and volume.
The effect of the TPS on Norwood outcomes is relatively
modest compared with that of the other independent risk
factors measured in the SVR trial. This was, in part, because
the regression models in the present study could not include
the intraoperative and postoperative variables that are in the
causal pathway of the factors on which calculation of
the TPS is based. For example, in an earlier report from
the SVR trial,30 extracorporeal membrane oxygenation
and an open sternum on the day of the Norwood procedure
were among the most powerful independent predictors of
30-day and hospital mortality and the interval to first
extubation after the Norwood procedure, the primary
outcome in our study. Similarly, the independent
predictors of interstage mortality included the use of a
modified Blalock-Taussig shunt rather than a right
ventricular-to-PA shunt in subjects with no or mild
postoperative atrioventricular valve regurgitation and
greater number of post-Norwood complications.31 Our
regression models did, however, consider patient and
preoperative medical risk factors previously shown to be
independent risk factors of adverse outcomes before
Norwood discharge and in the interstage, such as low
birthweight,30 lower gestational age,31 and anatomic
factors31 (eg, the presence of aortic atresia or mitral atresia).
The TPS is among the most modifiable of the various risk
factors demonstrated in the SVR trial.
The TPS has been based on the transthoracic echo-
cardiogram performed before hospital discharge. A
scoring system for intraoperative echocardiography might
provide timely information and elucidate components of
an ‘‘inadequate’’ procedure that would benefit from
immediate intraoperative revision. Recent work has shown
that intraoperative revision of residual lesions improves
in-hospital outcomes.5gery c November 2014
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We were unable to calculate the TPS for one third of the
subjects because of missing or incomplete protocol
echocardiograms, together with the absence of reinterven-
tions at the sites of initial surgical correction. Mortality
was a secondary study outcome, because its analysis with
respect to TPS was conditional on early survival (ie, the
vast majority of subjects without echocardiograms [91%]
died early—before the protocol echocardiogram was
performed [class 4 subjects]). Although it seems likely
that most of these subjects would have had a class 3 TPS,
our study design did not allow us to test this hypothesis
directly. In the sensitivity analyses, assuming that all these
subjects had either class 1 or 3 TPS, the TPS remained an
independent predictor of mortality before Norwood
discharge. The primary endpoint of the present study, the
interval to initial extubation, might have been affected by
center practices and protocols. However, the center was
considered as a covariate in the multivariable models, and
other measures of overall hospital complexity, such as the
LOS in the cardiac intensive care unit, would have been
even more affected by center variation.32 Finally, the
components of the TPS were derived by the consensus of
experts, rather than by determination of cutpoints from
analyses of prospectively collected data, and TPS classes
1 and 2 were often similar in their prediction of the
outcomes. A prospective multicenter study of the Pediatric
Heart Network, currently in its planning phase, will refine
the cutpoints of the TPS using both a multicenter expert
panel and an analysis of prospectively collected data.
CONCLUSIONS
The TPS is an independent predictor of both early and
mid-term outcomes in patients with hypoplastic left heart
syndrome and other single right ventricle anomalies
undergoing the Norwood procedure. With additional
multicenter refinement and testing, the TPS could be used
as a tool for quality improvement, with the potential for
impact, not only on patient outcomes, but also on resource
usage in this costly, high-risk population.
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Norwood procedure. J Thorac Cardiovasc Surg. 2012;144:915-21.MMENTARYUtility of the technical performance score for the Norwood
operation. every score should know its limitationsTara Karamlou, MDThe article by Nathan and colleagues1 in this issue of the
Journal provides additional data regarding the relationship
of the technical performance score (TPS) to outcomes after
the Norwood procedure among participants of the Single
Ventricle Reconstruction Trial (SVR). Nathan and
colleagues1 conducted an ad hoc analysis of the SVR cohort
of neonates undergoing the Norwood operation. By means
of discharge echocardiography, available for 365 (65%)
of the 549 patients in the study, a TPS category of optimal
(72%), adequate (12%), or inadequate (17%), was
assigned. The components of the TPS, which are weighted
equally, include restriction at the atrial septum, residual
aortic arch obstruction, and intervention on the chosen
source of pulmonary blood flow. Neurodevelopmental
outcome was assessed with the Bayley Scales of Infant
Development (2nd edition). By means of multivariable
regression, Nathan and colleagues1 found that better TPS
was associated with shorter time to initial extubation,
improved transplant-free survival before discharge after
the Norwood operation, shorter hospital stay, lowerprevalence of unplanned interstage interventions, and better
Bayley Scales Psychomotor Developmental Index (PDI)
subscale scores at 14 months.
I applaud Nathan and colleagues1 for extending their
considerable work in this area and for using a
multi-institutional cohort with prospectively collected
data. The TPS has promise as the first objective tool that
can both inform care and provide a platform for individual
surgeon evaluation. There are important limitations to this
study, however, that should temper Nathan and colleagues’
conclusions1 regarding the impact of the TPS on post-
Norwood outcomes.
Factors that affect outcomes after the Norwood operation
have been studied in detail with both prospective and retro-
spective data. It is clear from the majority of these studies
that surgeon, institution, and patient factors play critical
roles; however, the relative contributions of each compo-
nent remain unknown and vary with different lesions and
procedures. In analysis of arguably the best data collection
available,2-4 surgeon factors in the Norwood operation,
including volume and experience (ostensibly a surrogate
for technical performance), were identified as having
minor influence on mortality relative to center or patientCalifornia, San Francisco, 513 Parnassus Ave, Suite S-549, San Francisco,
CA 94143 (E-mail: tara.karamlou@ucsfmedctr.org).
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APPENDIX E1. SINGLE VENTRICLE
RECONSTRUCTION TRIAL PARTICIPANTS
National Heart, Lung, and Blood Institute: Gail Pearson,
Victoria Pemberton, Rae-Ellen Kavey, Mario Stylianou,
Marsha Mathis, Jonathan Kaltman
Network Chairperson: University of Texas Southwestern
Medical Center, Lynn Mahony
Data Coordinating Center: New England Research
Institutes, Lynn Sleeper (primary investigator [PI]), Sharon
Tennstedt (PI), Steven Colan, Lisa Virzi, Patty Connell,
Victoria Muratov, Lisa Wruck, Minmin Lu, Dianne
Gallagher, Anne Devine, Thomas Travison, David F. Teitel
Core Clinical Site Investigators: Children’s Hospital
Boston, Jane W. Newburger (PI), Peter Laussen, Pedro del
Nido, Roger Breitbart, Jami Levine, Ellen McGrath, Caro-
lyn Dunbar-Masterson; Children’s Hospital of New York,
Wyman Lai (PI), Beth Printz (currently at Rady Children’s
Hospital), Daphne Hsu (currently at Montefiore Medical
Center), William Hellenbrand (currently at Yale New
Haven Medical Center), Ismee Williams, Ashwin Prakash
(currently at Children’s Hospital Boston), Ralph Mosca
(currently at New York University Medical Center),
Darlene Servedio, Rozelle Corda, Rosalind Korsin, Mary
Nash; Children’s Hospital of Philadelphia, Victoria
L. Vetter (PI), Sarah Tabbutt (currently at the University
of California, San Francisco), J. William Gaynor (study
co-chairperson), Chitra Ravishankar, Thomas Spray, Meryl
Cohen, Marisa Nolan, Stephanie Piacentino, Sandra
DiLullo, Nicole Mirarchi; Cincinnati Children’s Medical
Center, D.WoodrowBenson (PI), Catherine Dent Krawcze-
ski, Lois Bogenschutz, Teresa Barnard, Michelle Hamstra,
Rachel Griffiths, Kathie Hogan, Steven Schwartz (currently
at the Hospital for Sick Children, Toronto), David Nelson,
David Morales; North Carolina Consortium: Duke
University, East Carolina University, Wake Forest Univer-
sity, Page A. W. Anderson (PI; deceased), Jennifer Li (PI),
Wesley Covitz, Kari Crawford, Michael Hines, James
Jaggers, Theodore Koutlas, Charlie Sang, Jr, Lori Jo Sutton,
Mingfen Xu, Kevin Hill; Medical University of South
Carolina, J. Philip Saul (PI), Andrew Atz, Girish Shirali,
Scott Bradley, Eric Graham, Teresa Atz, Patricia Infinger;
Primary Children’s Medical Center and University of
Utah, Salt Lake City, Utah, L. LuAnn Minich (PI), John
Hawkins (deceased), Michael Puchalski, RichardWilliams,
Linda Lambert, Jun Porter, Marian Shearrow, Peter Gruber;
Hospital for Sick Children, Toronto, Brian McCrindle (PI),
Joel Kirsh, Chris Caldarone, Elizabeth Radojewski,
Svetlana Khaikin, Susan McIntyre, Nancy Slater;
University of Michigan, Caren S. Goldberg (PI), Richard
G. Ohye (study chairperson), Cheryl Nowak, Jennifer
Hirsch-Romano; Children’s Hospital of Wisconsin, Nancy
Ghanayem (PI), James Tweddell, Kathy Mussatto, Michele
Frommelt, Lisa Young-Borkowski
Auxiliary Sites: Children’s Hospital Los Angeles, Alan
Lewis (PI), Vaughn Starnes, Nancy Pike, S. Ram Kumar;
Johns Hopkins All Children’s Heart Institute, Jeffrey
P. Jacobs (PI), James A. Quintessenza, Paul J. Chai, David
S. Cooper, J. Blaine John, James C. Huhta, Tina Merola,
Tracey Cox; Emory University, Kirk Kanter, William
Mahle, Joel Bond, Leslie French, Jeryl Huckaby; Nemours
Cardiac Center, Christian Pizarro, Carol Prospero, Julie
Simons, Gina Baffa; University of Texas Southwestern
Medical Center, Ilana Zeltzer (PI), Tia Tortoriello, Deborah
McElroy, Deborah Town
Angiography Core Laboratory: Duke University, John
Rhodes, J. Curt Fudge
Echocardiography Core Laboratories: Children’s Hospi-
tal of Wisconsin, Peter Frommelt; Children’s Hospital
Boston, Gerald Marx
Genetics Core Laboratory: Children’s Hospital of
Philadelphia, Catherine Stolle
Protocol Review Committee: Michael Artman
(chairperson), Erle Austin, Timothy Feltes, Julie Johnson,
Thomas Klitzner, Jeffrey Krischer, G. Paul Matherne
Data and Safety Monitoring Board: John Kugler
(chairperson), Rae-Ellen Kavey (executive secretary),
David J. Driscoll, Mark Galantowicz, Sally A. Hunsberger,
Thomas J. Knight, Holly Taylor, Catherine L. Webb
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FIGUREE1. Box plots of Bayley psychomotor developmental index (PDI) and mental developmental index (MDI) scores by technical performance score
(TPS) class. Those with class 1, optimal TPS, had higherMDI and PDI scores. Asterisk represents the mean, and the bottom, center, and top edges of the box
represent the 25th, 50th, and 75th percentiles.
TABLE E1. Modified technical performance score module for Norwood procedure used to assign TPS in the SVR cohort
Subprocedure Class 1 (optimal) Class 2 (adequate) Class 3 (inadequate)
Proximal arch reconstruction NA NA Reintervention
Distal arch reconstruction Peak gradient<20 mm Hg Peak gradient 20-40 mm Hg Reintervention or peak gradient>40 mm Hg
Coronary perfusion NA NA Reintervention
Atrial septectomy Mean gradient<2 mm Hg Mean gradient 3-4 mm Hg Reintervention or mean gradient>4 mm Hg
MBTS Patent Patent Reintervention
RV-PA conduit Patent Patent Reintervention
The final score is class 1 (optimal) if all subprocedure scores are optimal. The final score is class 2 (adequate) if any subprocedure score is adequate, but no subprocedure score is
inadequate. The final score is class 3 (inadequate) if any subprocedure score is inadequate. NA, Not assessed in SVR trial core laboratory;MBTS, modified Blalock-Taussig shunt;
RV-PA, right ventricle-to-pulmonary artery.
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TABLE E2. Patient and Norwood procedural characteristics
Characteristic Total (n) Value Median (IQR)
Demographic data
Male sex 549 340 (62)
Birth weight (kg) 549 3.1  0.5 3.1 (2.8-3.5)
Birth weight<2.5 kg 549 76 (14)
Gestational age (wk) 549 38.2  1.6 38 (37-39)
Gestational age<37 wk 549 64 (12)
Hispanic 539 101 (19)
Race 544
White 436 (80)
Black 86 (16)
Other 22 (4)
1-min Apgar (after imputation) 549 7.6  1.6 8 (8-9)
5-min Apgar (after imputation) 549 8.6  0.8 9 (8-9)
Before Norwood
Prenatal diagnosis of CHD 549 420 (77)
Fetal intervention 549 14 (3)
HLHS 549 474 (86)
Aortic atresia 549 343 (63)
Obstructed pulmonary venous return 549 19 (4)
Highest lactate level (mmol/L; after imputation) 549 3.9  2.9 3.0 (2.5-4.0)
Ever intubated 547 263 (48)
For apnea 547 75 (14)
For shock 547 14 (3)
For respiratory failure 547 72 (13)
For metabolic acidosis 547 31 (6)
Cardiac and other surgery 549
Yes 11 (2)
No 538 (98)
Cardiac catheterization intervention 549
Yes 28 (5)
No 521 (95)
Complications 549
Yes 153 (28)
No 396 (72)
No. of complications 0.6  1.2 0 (0-1)
Age at Norwood procedure (d) 549 5.8  4.1 5 (3-7)
Weight at Norwood procedure (kg) 549 3.1  0.5 3.2 (2.8-3.5)
Norwood hospitalization*
Crossclamp time (min) 549 56.0  23.4 53 (40-67)
Total support time (min) 549 143.9  54.1 139 (105-171)
Perfusion type 544
DHCA 296 (54)
RCP 130 (24)
DHCA and RCP 118 (22)
DHCA duration (min) 544 31.7  23.2 0 (0-51)
RCP duration (min) 546 23.8  29.2 0 (0-117)
Exterior diameter of AA at STJ (mm) 535 3.12  1.66 2.5 (2.0-4.0)
ICU total LOS (d) 539 25.8  33.8 14.0 (9.0-28.0)
Open sternum postoperatively 544 426 (78)
Pacemaker insertion at or after operation 544 6 (1)
Oxygen saturation at discharge (%) 436 82.4  4.9 82 (80-85)
Data presented as n, n (%), or mean  standard deviation, unless otherwise noted. IQR, Interquartile range; CHD, congenital heart disease; HLHS, hypoplastic left heart
syndrome; DHCA, deep hypothermic circulatory arrest; RCP, regional cerebral perfusion; AA, ascending aorta; STJ, sinotubular junction; ICU, intensive care unit; LOS, length
of stay. *These postbaseline factors were not used as candidate predictors in the modeling of outcomes.
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TABLE E3. Baseline characteristics of patients with and without TPSs
Characteristic TPS assignable (class 1, 2, 3) Class 4* Class 5y P value
Patients (n) 356 56 137
Center <.001z
Demographic data
Male sex 216 (61) 29 (52) 95 (69) .05
Birth weight (kg) 3.1  0.5 2.9  0.6 3.2  0.5 .02z
Birth weight<2.5 kg 44 (12) 17 (30) 15 (11) <.001z
Gestational age (wk) 38.2  1.6 37.6  1.9 38.3  1.5 .03z
Gestational age<37 wk 37 (10) 13 (23) 14 (10) .02z
Hispanic 74 (21) 5 (9) 22 (16) .09
Race .73
White 287 (82) 43 (77) 106 (78)
Black 50 (14) 11 (20) 25 (18)
Other 15 (4) 2 (4) 5 (4)
1-min Apgar (after imputation) 8.0 (8.0-9.0) 8.0 (8.0-8.0) 8.0 (8.0-8.0) .23
5-min Apgar (after imputation) 9.0 (8.0-9.0) 9.0 (8.0-9.0) 9.0 (8.0-9.0) .11
SES score 0.1  5.1 0.8  5.9 0.3  4.6 .43
Below poverty level (%) 12.6  12.6 14.2  14.2 13.2  12.0 .67
Pre-Norwood
Prenatal diagnosis of CHD 274 (77) 43 (77) 103 (75) .92
Fetal intervention 8 (2) 0 (0) 6 (4) .18
HLHS 307 (86) 44 (79) 123 (90) .12
Aortic atresia 217 (61) 35 (63) 91 (66) .53
Obstructed pulmonary venous return 8 (2) 4 (7) 7 (5) .08
Highest lactate level (mmol/L) 3.9  2.9 3.7  2.6 3.9  3.0 .87
Ever intubated 162 (46) 32 (57) 69 (50) .27
For apnea 41 (12) 9 (16) 25 (18) .14
For shock 9 (3) 3 (5) 2 (2) .30
For respiratory failure 48 (14) 7 (12) 17 (12) .93
For metabolic acidosis 21 (6) 3 (5) 7 (5) .93
Cardiac and other surgery 7 (2) 0 (0) 4 (3) .42
Cardiac catheterization intervention 18 (5) 3 (5) 7 (5) .99
Complications 98 (28) 19 (34) 36 (264) .54
At Norwood operation
Age (d) 5.8  4.2 5.5  3.5 5.9  3.9 .82
Weight (kg) 3.1  0.5 2.9  0.6 3.1  0.5 .004z
Weight-for-age z score (WHO) 0.6  1.2 1.2  1.3 0.6  1.1 .010z
Exterior diameter of AA (mm) 3.1  1.6 3.0  1.6 3.2  1.8 .79
Genetic syndrome or other anomalies <.001z
Yes 78 (22) 6 (11) 35 (25)
No 175 (49) 7 (13) 73 (53)
Unknown 103 (29) 43 (77) 29 (21)
Data presented as n (%), mean  standard deviation, or median (interquartile range). TPS, Technical performance score; SES, socioeconomic status; CHD, congenital heart
disease; HLHS, hypoplastic left heart syndrome; WHO, World Health Organization; AA, ascending aorta. *No TPS assigned because no echocardiogram performed and no
unplanned reinterventions required before discharge. yNo TPS assigned because of an incomplete echocardiogram and no unplanned reinterventions required before discharge.
zStatistically significant.
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TABLE E4. Early mortality or transplantation rate stratified by TPS class
Variable Patients (n) Transplantation or death (n) Transplantation (n) Death (n)
Overall 549 101 (21) 9 92
TPS
Class 1 (optimal) 255 10 (4) 3 7
Class 2 (adequate) 42 3 (7) 0 3
Class 3 (inadequate) 59 16 (27) 2 14
Class 4 (no ECG, no RI) 56 54 (96) 3 51
Class 5 (incomplete ECG, no RI) 137 18 (13) 1 17
Data in parentheses are percentages. TPS, Technical performance score; ECG, echocardiogram; RI, reintervention.
TABLE E5. Prestage II reintervention stratified by TPS
Variable Patients (n) Reintervention OR (95% CI) P value
Overall 329 77 (23)
TPS .003*
Class 1 (optimal) 247 47 (19) 0.30 (0.15-0.62)
Class 2 (adequate) 39 17 (44) 1.78 (0.72-4.42)
Class 3 (inadequate) 43 13 (30) Reference
Data presented as n (%), unless otherwise noted. TPS, Technical performance score; OR, odds ratio; CI, confidence interval. *Statistically significant.
TABLE E6. Late mortality or transplantation from Norwood discharge to 3 years after randomization
Variable Patients (n) Transplantation or death (n) Transplantation (n) Death (n)
Overall 448 96 (21) 11 85
TPS
Class 1 (optimal) 245 55 (55/242 [23])* 6 49
Class 2 (adequate) 39 5 (5/38 [13])* 1 4
Class 3 (inadequate) 43 9 (9/42 [21])* 2 7
Class 4 (no ECG) 2 2 (100) 0 2
Class 5 (incomplete ECG) 119 25 (26) 2 23
Data in parentheses or brackets are percentages. The data of the subjects who died or underwent cardiac transplantation before Norwood discharge were excluded. TPS, Technical
performance score; ECG, echocardiogram. *The denominators reflect the exclusion of the 5 patients who withdrew 13 to 16 months after randomization.
TABLE E7. Multivariable Cox regression model for late mortality or
transplantation from Norwood discharge to 3 years after
randomization (n ¼ 327)
Variable HR 95% CI P value
Gestational age<37 wk .010*
Yes 2.32 1.23-4.41
No Reference
Obstructed pulmonary venous return 5.43 1.66-17.8 .005*
Highest lactate level (mmol/L) 1.11 1.05-1.18 <.001*
TPS .390
Class 1 (optimal) 1.37 0.67-2.82
Class 2 (adequate) 0.80 0.26-2.45
Class 3 (inadequate) Reference
The data of subjects who died or underwent cardiac transplant before Norwood
discharge were excluded. HR, Hazard ratio; CI, confidence interval; TPS, technical
performance score. *Statistically significant.
TABLE E8. Types of unplanned reinterventions in anatomic areas of
surgical repair during Norwood hospitalization in class 3 patients
stratified by shunt type
Unplanned reintervention BTS (n) RVPAS (n)
Shunt 20 24
Surgical thrombectomy 2 0
Catheter RI 6 10
Shunt crossover 5 7
Surgical revision 7 7
Arch 3 1
Branch PA 4 2
ASD 1 0
Total 28 27
For the entire cohort of 55 patients, 9 patients had no ECGs and 13 had incomplete
ECGs. BTS, Blalock-Taussig shunt; RVPAS, right ventricle-to-pulmonary artery
shunt; RI, reintervention; PA, pulmonary artery; ASD, atrial septal defect.
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TABLE E9. Echocardiographic findings of 59 class 3 patients
Arch peak
velocity (m/s)
ASD mean
gradient (mm Hg) RI Patients (n)
<2.25* <2 Proximal arch 1
2.25-3.2y <2 Proximal arch 1
Missing Missing Proximal arch 1
2.25-3.2 >4 Atrial septectomy 1
<2.25 >4 Atrial septectomy
and RI
1
Missing Missing Shunt RI 8
Missing <2 Shunt RI 13
<2.25 <2 Shunt RI 27
2.25-3.2 Missing Shunt RI 1
2.25-3.2 <2 Shunt RI 1
<2.25 >4 None 1
>3.2z <2 None 3
ASD, Atrial septal defect; RI, reintervention. *<2.25 m/s ¼ <20 mm Hg.
y2.25-3.2 m/s ¼ 20-40 mm Hg. z>3.2 m/s ¼>40 mm Hg.
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